During cell therapy development, some scientists are moving away from viral transfection and toward electroporation for introducing CRISPR systems and other nucleic acid payloads. As electroporation systems for both large- and small-scale cell production continue to improve, this method serves as a quicker, simpler, and safer alternative to viral transfection.
Download this article from Thermo Fisher Scientific to learn how scientists employ electroporation in place of viral delivery for cell therapy applications and beyond.
